CalciMedica is trading 5.7% down today at $0.69 as the stock continues to digest the impact of recent negative developments and trial setbacks.
- The stock remains volatile following the discontinuation of its Phase 2 KOURAGE trial and recent Nasdaq delisting notices.
- Today's downward move appears driven by weak sentiment and light-liquidity trading, with no new regulatory filings or press releases issued today.
- Shares are currently pulling back after experiencing a sharp rebound during the previous week.